Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Michelle Katherine Haas

TitleAssistant Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Shen D, Ayala A, Reves R, Haas M, Khurana R. Tuberculosis infection prevalence and treatment completion among refugees in the United States. Int J Infect Dis. 2025 Feb; 151:107361. PMID: 39672534.
      View in: PubMed
    2. Nguyen MH, Haas MK, Kasperbauer SH, Calado Nogueira de Moura V, Eddy JJ, Mitchell JD, Khare R, Griffith DE, Chan ED, Daley CL. Executive Summary: State-of-the-Art Review: Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects. Clin Infect Dis. 2024 10 15; 79(4):805-806. PMID: 39405482.
      View in: PubMed
    3. Nguyen MH, Haas MK, Kasperbauer SH, Calado Nogueira de Moura V, Eddy JJ, Mitchell JD, Khare R, Griffith DE, Chan ED, Daley CL. Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects. Clin Infect Dis. 2024 10 15; 79(4):e27-e47. PMID: 39405483.
      View in: PubMed
    4. Asare-Baah M, Salmon-Trejo LAT, Venkatappa T, Garfein RS, Aiona K, Haas M, S?raphin MN. Factors Associated With the Discontinuation of Two Short-Course Tuberculosis Preventive Therapies in Programmatic Settings in the United States. Open Forum Infect Dis. 2024 Jun; 11(6):ofae313. PMID: 38915338.
      View in: PubMed
    5. Aiona K, Bacon E, Podewils LJ, Haas MK. The disparate impact of age-based COVID-19 vaccine prioritization by race/ethnicity in Denver, Colorado. Health Policy Open. 2022 Dec; 3:100074. PMID: 35892113.
      View in: PubMed
    6. Haas MK, Aiona K, Erlandson KM, Belknap RW. Higher Completion Rates With Self-administered Once-weekly Isoniazid-rifapentine Versus Daily Rifampin in Adults With Latent Tuberculosis. Clin Infect Dis. 2021 11 02; 73(9):e3459-e3467. PMID: 32915203.
      View in: PubMed
    7. Schultz J, Beeson A, Newton T, Gannon J, Frank A, Franco-Paredes C, Haas M, Venci J. Impact of An Internal Medicine-Pediatrics Residency Quality Improvement Project to Increase Latent Tuberculosis Screening. Am J Med Sci. 2021 05; 361(5):670-672. PMID: 33775427.
      View in: PubMed
    8. Bonfiglio G, Rosal K, Henao-Mart?nez A, Franco-Paredes C, Poeschla EM, Moo-Young J, Seefeldt T, Dunlevy H, Haas M, Young J. The long journey inside immigration detention centres in the USA. J Travel Med. 2020 11 09; 27(7). PMID: 32463091.
      View in: PubMed
    9. Gaensbauer J, Young J, Harasaki C, Aiona K, Belknap R, Haas MK. Interferon-Gamma Release Assay Testing in Children Younger Than 2 Years in a US-Based Health System. Pediatr Infect Dis J. 2020 09; 39(9):803-807. PMID: 32804462.
      View in: PubMed
    10. Flynn AG, Aiona K, Haas MK, Reves R, Belknap R. Clinical Characteristics of Active Tuberculosis Diagnosed After Starting Treatment for Latent Tuberculosis Infection. Clin Infect Dis. 2020 08 22; 71(5):1320-1323. PMID: 31773132.
      View in: PubMed
    11. Haas MK, Belknap RW. Diagnostic Tests for Latent Tuberculosis Infection. Clin Chest Med. 2019 12; 40(4):829-837. PMID: 31731987.
      View in: PubMed
    12. Haas MK, Reves R. Strong Community-Public Health Partnerships May Help Us Move Closer to Tuberculosis Elimination. Am J Public Health. 2019 07; 109(7):958-959. PMID: 31166724.
      View in: PubMed
    13. Ruoff K, Kilic T, Devant J, Koromyslova A, Ringel A, Hempelmann A, Geiss C, Graf J, Haas M, Roggenbach I, Hansman G. Structural Basis of Nanobodies Targeting the Prototype Norovirus. J Virol. 2019 03 15; 93(6). PMID: 30602609.
      View in: PubMed
    14. Haas MK, Belknap RW. Updates in the Treatment of Active and Latent Tuberculosis. Semin Respir Crit Care Med. 2018 Jun; 39(3):297-309. PMID: 30071545.
      View in: PubMed
    15. Gersh JK, Feldman Z, Greenberger E, Chandra A, Friedman HM, Ho-Foster A, Haas MK. Tuberculosis among individuals with community-acquired pneumonia presenting to emergency in Gaborone, Botswana. J Public Health Afr. 2018 May 21; 9(1):803. PMID: 30079172.
      View in: PubMed
    16. Gaensbauer J, Aiona K, Haas M, Reves R, Young J, Belknap R. Better Completion of Pediatric Latent Tuberculosis Treatment Using 4 Months of Rifampin in a US-based Tuberculosis Clinic. Pediatr Infect Dis J. 2018 03; 37(3):224-228. PMID: 28777204.
      View in: PubMed
    17. Pedela RL, Shihadeh KC, Knepper BC, Haas MK, Burman WJ, Jenkins TC. Preferential Use of Nitrofurantoin Over Fluoroquinolones for Acute Uncomplicated Cystitis and Outpatient Escherichia coli Resistance in an Integrated Healthcare System. Infect Control Hosp Epidemiol. 2017 04; 38(4):461-468. PMID: 28052786.
      View in: PubMed
    18. Haas MK, Dalton K, Knepper BC, Stella SA, Cervantes L, Price CS, Burman WJ, Mehler PS, Jenkins TC. Effects of a Syndrome-Specific Antibiotic Stewardship Intervention for Inpatient Community-Acquired Pneumonia. Open Forum Infect Dis. 2016 Oct; 3(4):ofw186. PMID: 27747254.
      View in: PubMed
    19. Haas MK, Daley CL. Mycobacterial Lung Disease Complicating HIV Infection. Semin Respir Crit Care Med. 2016 Apr; 37(2):230-42. PMID: 26974300.
      View in: PubMed
    20. Yogo N, Haas MK, Knepper BC, Burman WJ, Mehler PS, Jenkins TC. Antibiotic prescribing at the transition from hospitalization to discharge: a target for antibiotic stewardship. Infect Control Hosp Epidemiol. 2015 Apr; 36(4):474-8. PMID: 25782905.
      View in: PubMed
    21. Jenkins TC, Knepper BC, Shihadeh K, Haas MK, Sabel AL, Steele AW, Wilson ML, Price CS, Burman WJ, Mehler PS. Long-term outcomes of an antimicrobial stewardship program implemented in a hospital with low baseline antibiotic use. Infect Control Hosp Epidemiol. 2015 Jun; 36(6):664-72. PMID: 25740560.
      View in: PubMed
    22. Reid MJ, Haas MK, Sedigeng P, Ramogola-Masire D, Friedman HM, Ho-Foster A. Leveraging HIV Programming to Enhance Access to Noncommunicable Disease Care in Southern Botswana. J Int Assoc Provid AIDS Care. 2016 Jan-Feb; 15(1):7-10. PMID: 25656859.
      View in: PubMed
    23. Haas MK, Levy DN, Folkvord JM, Connick E. Distinct patterns of Bcl-2 expression occur in R5- and X4-tropic HIV-1-producing lymphoid tissue cells infected ex vivo. AIDS Res Hum Retroviruses. 2015 Mar; 31(3):298-304. PMID: 25353356.
      View in: PubMed
    24. Jenkins TC, Haas MK, Shihadeh KC, Lavonas EJ. Trimethoprim-sulfamethoxazole for skin and soft tissue infections--let us not forget the risks. Ann Emerg Med. 2014 Jun; 63(6):783-4. PMID: 24841401.
      View in: PubMed
    25. Meditz AL, Haas MK, Folkvord JM, Melander K, Young R, McCarter M, Mawhinney S, Campbell TB, Lie Y, Coakley E, Levy DN, Connick E. HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo. J Virol. 2011 Oct; 85(19):10189-200. PMID: 21813616.
      View in: PubMed
    Haas's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (133) concept(s)
    _
    Co-Authors Expand Description
    See all (20) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)